Cytocom, Inc is a private late-stage biopharmaceutical company focused on the development of T-cell activation immunotherapy, to treat life-threatening infections, representing a fundamentally new treatment approach in the infectious disease and autoimmune market that are designed to overcome key issues associated with current therapies, including serious adverse events ("SAE"), drug resistance, short duration of response, negative impact on the human microbiome, and lack of differentiation between treatment alternatives.
| Website | http://www.cytocom.com |
| Revenue | $405000 |
| Employees | View employees |
| Address | 3001 Aloma Ave, Winter Park, Florida 32792, US |
| Phone | +1 888-629-4155 |
| Fax | (321) 441-9763 |
| Technologies |
JavaScript
,
HTML
,
PHP
+27 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Health Care |
| Competitors | Novartis, Pfizer, AstraZeneca, Amgen, Regeneron, Gilead Sciences, Moderna Therapeutics, CureVac, Sangamo Therapeutics, Inc., AnaptysBio +45 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Cytocom employee's phone or email?
Cytocom Questions
The Cytocom annual revenue was $405000 in 2026.
Cytocom is based in Winter Park, Florida.
The NAICS codes for Cytocom are [54, 541, 5417].
The SIC codes for Cytocom are [283, 28].
